Emedgene
Series AEmedgene raised €5.2M in a Series A round in Jan 2019. The company is based in Mazor, Israel. Investors in the round: Olive Tree Ventures. Data as of Nov 2026.
Amount raised
€5.2M
€5,240,175
Native amount
6,000,000 USD
Stage
Series A
series a
Investors
1
Provenance & confidence
High confidenceAmount
6,000,000 USD
ECB-at-date → €5.2M · rate 1.145 on 2018-12-31
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Other rounds
same companyThis is the company's only recorded round.